Devices

A hybrid implanted-plus-external functional electrical stimulation (FES) system using a multi-contact cuff on the common peroneal nerve to restore ankle dorsiflexion during gait.

Device — Peripheral nerve

ActiGait implanted drop-foot stimulator (common peroneal nerve multi-contact cuff)

PNI · FES · drop foot · peroneal nerve · cuff · gait · peripheral nerve · stimulation

ActiGait implanted drop-foot stimulator (common peroneal nerve multi-contact cuff)

One-line verdict: A hybrid implanted-plus-external FES system that uses a multi-contact cuff on the common peroneal nerve to selectively restore ankle dorsiflexion during gait.

Quick tags: Stimulation · Channels: multi-contact cuff (often described as 4-channel control) · Species: Human


Overview

What it is: ActiGait is a partly implantable peroneal nerve stimulation system: an implanted stimulator body connected to a nerve cuff electrode wrapped around the common peroneal nerve, plus external components used to trigger stimulation patterns across gait phases.

Why it matters: It is a concrete, real-world example where cuff contact geometry + multi-channel programming yields functional selectivity (recruitment shaping) in a packaged clinical neuroprosthesis.

Most comparable devices: surface FES drop-foot systems (non-implant); other implantable peroneal nerve stimulators.


Spec Card Grid

Identity

  • Device name: ActiGait implanted drop-foot stimulator
  • Canonical ID: BTSD-PNI-0002
  • Org / manufacturer: ActiGait is a commercial system (manufacturer/branding varies by era and region in publications and clinical materials)
  • First demonstrated (year): clinical studies published in the 2000s–2010s
  • First implanted (year): mid-2000s era (reported)
  • Species: human
  • Regulatory / trial status: used clinically in Europe in multiple cohorts; evidence includes prospective studies
  • Primary use: stimulation (FES)
  • Primary target: common peroneal (fibular) nerve, proximal to bifurcation

Geometry & Architecture

  • Interface type: peripheral nerve cuff (multi-contact, multi-channel stimulation)
  • Penetrating?: no
  • Form factor: implanted stimulator body + cable + cuff electrode; plus external trigger/controller
  • Array layout: multi-contact cuff enabling multiple stimulation “channels” around the nerve (exact grouping is implementation-specific)
  • Footprint (mm): not consistently reported in open clinical outcomes papers
  • Insertion method: surgical placement of cuff around common peroneal nerve proximal to bifurcation; implant body placement in thigh
  • Anchoring method: cuff placement + cable routing/strain relief
  • Packaging location: hybrid (implanted stimulator + cuff; external controller/trigger)

Electrode & Channel Physics

  • Channel count: reported as multi-channel; often described as 4-channel functional control (implementation-dependent)
  • Active sites used (vs total): multi-contact cuff (some reports describe ~12 contacts; confirm per specific publication)
  • Electrode material: not pinned here
  • Recording modality: N/A
  • Stimulation capability: yes

Tissue Interface & Bioresponse

  • Target tissue: extraneural cuff on peroneal nerve trunk
  • Vascular disruption risk: low–moderate (surgical dissection; compression risk if misfit)
  • Micromotion sensitivity: low–moderate (strain relief important)
  • Encapsulation: expected; long-term cohorts exist
  • Typical failure mode: hardware issues, infection, threshold drift/selectivity changes, revision

System Architecture

  • Onboard electronics: stimulation in implanted body; none in cuff
  • Control path: external trigger/controller coordinates stimulation timing (gait-phase)
  • Power: hybrid architecture (model-dependent)
  • MRI compatibility: model-specific

Performance Envelope

  • Typical yield (acute): selective dorsiflexion recruitment via programming
  • Typical yield (chronic): long-term gait improvements reported across cohorts
  • Revision / explant: occurs in real-world cohorts (rates vary)

Clinical / Preclinical Evidence

  • Evidence base: prospective cohort data in central drop foot (e.g., post-stroke)
  • Primary outcomes: gait speed/endurance, functional dorsiflexion, usability
  • Key limitations of evidence: mixed etiologies and heterogeneous rehab protocols

Engineering Verdict

Strengths:

  • multi-contact cuff enables functional selectivity for gait
  • reduces daily placement burden vs surface FES

Limitations / failure modes:

  • requires surgery and implanted hardware maintenance
  • selectivity depends on nerve anatomy + cuff placement

References

  • Martin KD, et al. Restoration of ankle movements with the ActiGait implantable drop foot stimulator: a safe and reliable treatment option for permanent central leg palsy. J Neurosurg. 2016;124(1):70–76. doi: 10.3171/2014.12.JNS142110. PubMed: https://pubmed.ncbi.nlm.nih.gov/26207599/